Teva charged — again — for alleged role in fixing generic drug prices, this time by the Department of Justice

The docket keeps piling up for Teva.

Late Tuesday, the Justice Department became the latest in a long string of prosecutors to accuse the Israeli drugmaker of malfeasance, charging the company with three counts of conspiring to fix generic drug prices. These new allegations come just a week after Teva $TEVA was sued by New York over its role in the opioid epidemic and by federal prosecutors over its purported scheme to defraud Medicare.